Issels Integrative Immuno-Oncology September 29, 2016  

University Shares Vision for Cancer Treatments of the Future

Dear Friend,

Recently we marked the annual observance of World Cancer Day, an event that originated in 2000 during the first World Summit against Cancer. Professor Colin Goding, a cancer researcher at Oxford University, took the opportunity to sit down for an interview about the current and future state of cancer treatment.

How researchers study cancer

According to Dr. Goding, the cellular events leading to the development of cancer are relatively complicated. Our bodies have systems to block mutated cells that lead to tumors, so those systems need to break down, allowing the mutations to take hold while accelerator cells push growth into overdrive.

Melanoma, a type of skin cancer, is one of the more common forms of the disease. It begins in the cells that manufacture melanin, which is a pigment controlling skin, eye and hair color. Dr. Goding cited melanoma as a good model for researchers to follow all stages of development, as opposed to forms like lung cancer that have already progressed by the time symptoms present.

Where does treatment go from here?

Dr. Goding sees the most promise for the future in two methods that are used in our cancer immunotherapy centers. One is the ongoing development of drugs that reactivate the body's immune system to attack cancer cells. The other is a focus on changing the micro-environment, which consists of the elements involved in the growth or regression of tumors.

Our Issels® cancer immunotherapy centers have been ahead of the curve in the use of non-toxic therapies that stimulate the immune system and target a tumor's micro-environment. Visit our website to learn more about our personalized treatment protocols today.

University Shares Vision for Cancer Treatments of the Future

Read more interesting articles on the "Issels Cancer Immunotherapy" news/blog posted every Tuesday and Thursday. Check It Out Now »

Nanotech Methods May Be the Future of Cancer Treatment

At Rice University they are blowing up cancer cells with nanoparticle "bombs." Like integrative immunotherapy, the new cancer-fighting technique kills cancer cells without harming surrounding healthy cells. Experimental trials have been so successful destroying aggressive and resistant cancer cells, particularly in the head and neck areas that human trials are expected to begin in the near future.

Get the Full Story!

Theranostic Agent and Infrared Light Allow for Improved Cancer Surgery

Phototherapy is a field holding promise as a valuable adjunct to current primary cancer treatments of surgery, chemotherapy and radiation. Its unique nature can help surmount the hurdles presented by forms of cancer that have developed a resistance to drug therapy. A study at OSU involved a single-agent system using silicon napthalocyanine, a substance considered to be "theranostic" because it has both therapeutic and diagnostic applications. The compound causes cancer cells to glow under near-infrared light, allowing a surgeon to have a clearer view of the tumor. In addition, the heat generated by the substance kills any remaining cancer cells.

Get the Full Story!

Videos – What Do Patients Say About Their Experience?

Watch videos of patients who share their own experiences at the Issels clinics with you. Listen to their stories and cancer journeys.

Get the Full Story!

Learn More

Testimonials »

Treatments »

Vaccines »

Statistics »

History »

Locations »

Contact Us »

Connect With Us:

Google +

Contact Info:

Phone: 888-447-7357


Treatments | Testimonials | Contact Us